Q1 2026 Supernus Pharmaceuticals Inc Earnings Call Transcript
Good afternoon and welcome to Supernus Pharmaceuticals First Quarter 2026 Financial Results Conference Call.
At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time. As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo of ICR Healthcare, Investor Relations Representative for Supernus Pharmaceuticals. You may begin.
Thank you. Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals' first-quarter 2026 financial results conference call. Today, after the close of the market, the company issued a press release announcing these results. On the call with me today are Supernus' Chief Executive Officer, Jack Khattar, and Chief Financial Officer, Tim Dec. Today's call is being made available via the Investor Relations section of the company's website at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
